The earnings call reflected a positive outlook with strong revenue growth, increased earnings per share, successful product launches, and significant customer wins. However, challenges like tariff impacts and increased inventory levels were noted. Overall, the highlights outweigh the lowlights, indicating a positive sentiment.

Company Guidance

During Omnicell's second quarter 2025 financial results call, the company reaffirmed its full-year outlook for product bookings and annual recurring revenue, while modestly increasing its guidance for total revenues, non-GAAP EBITDA, and non-GAAP earnings per share due to strong first-half performance. The quarter saw total revenue of $291 million, up 5% from the previous year, with GAAP earnings per share rising to $0.12 from $0.08. Non-GAAP earnings per share were $0.45, while non-GAAP EBITDA was $38 million. The company anticipates third-quarter revenues between $290 million and $300 million and full-year 2025 revenues between $1.13 billion and $1.16 billion. The call highlighted the strategic shift towards recurring revenue growth and technology platform expansion, including the OmniSphere platform, which received HITRUST CSF i1 certification. Omnicell also addressed tariff impacts, with mitigation efforts expected to reduce the annualized run rate by 2026.

Strong Revenue Growth

Total revenue was $291 million, representing an increase of $14 million or 5% over the second quarter of 2024 and an increase of $21 million or 8% compared to the previous quarter.

Increased Earnings Per Share

Second quarter 2025 earnings per share in accordance with GAAP were $0.12 compared to $0.08 in the second quarter of 2024 and a loss of $0.15 in the prior quarter.

OmniSphere Platform Certification

OmniSphere received HITRUST CSF i1 certification, affirming commitment to cybersecurity and operational excellence.

Successful Product Launches

Launch of MedVision and MedTrack - OR, enhancing visibility and inventory management in outpatient settings and operating rooms.

Positive Customer Wins

Significant deals with large health organizations in New Jersey, Nebraska, Northern Pennsylvania, and Southern and Central New York.

Improved Cash Flow

Free cash flow during the second quarter of 2025 was $27 million, an increase of $17 million compared to the prior quarter.

Stock Repurchase Program

Authorized new stock repurchase program of up to $75 million, with $16 million worth of stock repurchased as of June 30, 2025.

Omnicell (OMCL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OMCL Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 04, 2025	2025 (Q3)	0.36 / -	0.56	―	―	―
Jul 31, 2025	2025 (Q2)	0.27 / 0.45	0.51	-11.76% (-0.06)
May 06, 2025	2025 (Q1)	0.20 / 0.26	0.03	766.67% (+0.23)
Feb 06, 2025	2024 (Q4)	0.58 / 0.60	0.33	81.82% (+0.27)
Oct 30, 2024	2024 (Q3)	0.42 / 0.56	0.62	-9.68% (-0.06)
Aug 01, 2024	2024 (Q2)	0.14 / 0.51	0.57	-10.53% (-0.06)
May 02, 2024	2024 (Q1)	-0.09 / 0.03	0.39	-92.31% (-0.36)
Feb 08, 2024	2023 (Q4)	0.15 / 0.33	0.33	0.00% (0.00)
Nov 02, 2023	2023 (Q3)	0.47 / 0.62	1	-38.00% (-0.38)
Aug 01, 2023	2023 (Q2)	0.28 / 0.57	0.84	-32.14% (-0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OMCL Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$29.70	$31.01	+4.41%
May 06, 2025	$30.49	$25.66	-15.84%
Feb 06, 2025	$44.38	$39.43	-11.15%
Oct 30, 2024	$40.12	$53.05	+32.23%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Omnicell (OMCL) report earnings?

Omnicell (OMCL) is schdueled to report earning on Nov 04, 2025, After Close (Confirmed).

What is Omnicell (OMCL) earnings time?

Omnicell (OMCL) earnings time is at Nov 04, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OMCL EPS forecast?

OMCL EPS forecast for the fiscal quarter 2025 (Q3) is 0.36.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing